The impact of opioid use on the lower gastrointestinal tract is well described, but recent opioid crisis has caused increased awareness of the detrimental effects of these drugs on esophageal and gastroduodenal motility. Opioid use has been associated with increased incidence of spastic esophageal motility disorders and gastroduodenal dysfunction. Opioid receptors are present with high abundance in the myenteric and submucosal plexus of the enteric nervous system. Activation of these receptors leads to suppressed excitability of the inhibitory musculomotor neurons and unchecked tonic contraction of the autogenic musculature (such as the lower esophageal sphincter and the pylorus).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.14309/ajg.0000000000000354 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic opioid users with dysphagia are indistinguishable from symptomatic nonusers on functional lumen imaging probe evaluation.
Neurogastroenterol Motil
May 2023
Division of Gastroenterology, Washington University School of Medicine, St Louis, Missouri, USA.
Background: Opioid-induced esophageal dysmotility (OIED) includes spastic esophageal motility disorders, increasingly recognized in the contemporary opioid epidemic. We assessed functional lumen imaging probe (FLIP) findings in diagnosing OIED.
Methods: Symptomatic patients undergoing FLIP with no prior foregut surgery who completed validated questionnaires were identified and segregated into chronic opioid users and nonusers in this cohort study.
Endoscopic ultrasound: a powerful tool to modify treatment algorithms in opioid-induced achalasia.
Surg Endosc
August 2021
Department of Surgery, Division of Minimally Invasive Surgery, UC San Diego School of Medicine, University of California San Diego, San Diego, CA, USA.
Background: Opioid use in the U.S. has increased dramatically over the last 15 years, recently being declared a public health emergency.
View Article and Find Full Text PDFContinuing Medical Education Questions: November 2019.
Am J Gastroenterol
November 2019
Scripps Health, La Jolla, California.
Article Title: Opioid-Induced Foregut Dysfunction.
View Article and Find Full Text PDFOpioid-Induced Foregut Dysfunction.
Am J Gastroenterol
November 2019
Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
The impact of opioid use on the lower gastrointestinal tract is well described, but recent opioid crisis has caused increased awareness of the detrimental effects of these drugs on esophageal and gastroduodenal motility. Opioid use has been associated with increased incidence of spastic esophageal motility disorders and gastroduodenal dysfunction. Opioid receptors are present with high abundance in the myenteric and submucosal plexus of the enteric nervous system.
View Article and Find Full Text PDFAn update on prucalopride in the treatment of chronic constipation.
Therap Adv Gastroenterol
November 2017
Division of Gastroenterology and Hepatology, The Methodist Hospital, 6550 Fannin St, SM 1201, Houston, TX 77030, USA.
Chronic constipation (CC) is a highly prevalent and often under-appreciated gastrointestinal disorder associated with significant impairment in quality of life. Symptoms of constipation are typically present for a number of years prior to a patient seeking help. Lifestyle modifications followed by, or coupled with, over-the-counter laxatives represent the initial treatment option; however, relief for many is limited and dissatisfaction rates for these approaches remain high.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!